UnicoCell Biomed Co., Ltd.
6794
Rank in Stocks
#18636
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Share Price
$2.02
Last synced: 2026-11-19
Market Cap
$122.74M
Change (1 day)
-5.20%
Change (1 year)
-10.83%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade UnicoCell Biomed Co., Ltd. (6794)
Category
Healthcare
EPS for UnicoCell Biomed Co., Ltd. (6794)
EPS as of December 2025 TTM: $-0.06
According to UnicoCell Biomed Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.06. At the end of 2025 the company had an EPS of $-0.06, a decrease compared to its 2024 EPS of $-0.05.
EPS history for UnicoCell Biomed Co., Ltd. from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.06 | 0.33% |
| 2025 | $-0.06 | 25.94% |
| 2024 | $-0.05 | -5.91% |
| 2023 | $-0.05 | -29.15% |
| 2022 | $-0.07 | -13.20% |
| 2021 | $-0.08 | -23.94% |
| 2020 | $-0.11 | -2.43% |
| 2019 | $-0.11 | -19.52% |
| 2018 | $-0.14 | 4.93% |
| 2017 | $-0.13 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $-0.89 | 1,378.41% |
US
|
|
| $15.66 | -26,113.29% |
US
|
|
| $-7.07 | 11,644.19% |
US
|
|
| $-5.29 | 8,687.38% |
AU
|
|
| $12.73 | -21,249.83% |
BE
|
Questions about UnicoCell Biomed Co., Ltd.'s earnings per share (EPS)
What is UnicoCell Biomed Co., Ltd.'s earnings per share (EPS)?
UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.06, as of Dec 2025.
What was UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) was $-0.06, compared with $-0.05 in 2024.
How has UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) was highest in 2024 ($-0.05) and lowest in 2020 ($-0.11).
How does UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) compare with similar companies?
UnicoCell Biomed Co., Ltd.'s earnings per share (EPS) ($-0.06) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.